Resilience Announces Long-Term Financing of up to $825 Million to Accelerate CDMO Strategy
New Capital from Oak Hill Advisors to Drive Investment in Go-Forward Manufacturing Operations CINCINNATI--(BUSINESS WIRE)--National Resilience...
New Capital from Oak Hill Advisors to Drive Investment in Go-Forward Manufacturing Operations CINCINNATI--(BUSINESS WIRE)--National Resilience...
A Q&A with Nithin Stephen As the pharmaceutical and biotech industries continue to innovate at a rapid pace, the demand for fill/finish capabilities...
How Early-Phase Companies Can Future-Proof Their Cell Therapies The following was extracted from a conversation with Eytan Abraham “Q: How should...
For revolutionary gene therapies to reach their full therapeutic potential, high throughput process development workflows are needed to keep pace...
Are you an innovator company looking for a reliable and innovative partner? You have come to the right place.
Download this on demand presentation detailing our drug substance manufacturing and drug product fill/finish capabilities. Simplify your GENE to IND...